Kereiakes, Dean J <br/><br/>
Phase I drug and light dose-escalation trial of motexafin lutetium and far red light activation (phototherapy) in subjects with coronary artery disease undergoing percutaneous coronary intervention and stent deployment: procedural and long-term results.  [electronic resource] 

 -  Circulation  Sep 2003 
 - 1310-5 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Clinical Trial, Phase I; Journal Article 
<br/><br/><label>ISSN: </label>1524-4539 
<br/><br/><label>Standard No.: </label>10.1161/01.CIR.0000087602.91755.19  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Angioplasty, Balloon, Coronary<br/>Combined Modality Therapy<br/>Coronary Angiography<br/>Coronary Artery Disease--diagnostic imaging<br/>Dose-Response Relationship, Drug<br/>Dose-Response Relationship, Radiation<br/>Female<br/>Follow-Up Studies<br/>Humans<br/>Infusions, Intravenous<br/>Male<br/>Metalloporphyrins--administration & dosage<br/>Middle Aged<br/>Photochemotherapy--adverse effects<br/>Photosensitizing Agents--administration & dosage<br/>Stents<br/>Treatment Outcome